ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,112Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 1137

$1.2M Total Retail Price of All Prescriptions

Rank: 31 out of 1137

567 Patients Receiving at Least One Drug in Part D
77% Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Oklahoma
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

12% of this provider’s 567 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

26% of this provider’s 567 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
FUROSEMIDE 1,027 952 138 1 5
HYDROCODONE-ACETAMINOPHEN 899 607 144 S3 2 1
LEVOTHYROXINE SODIUM 833 765 107 3 3
LISINOPRIL 757 624 138 4 2
OMEPRAZOLE 717 586 128 5 4
POTASSIUM CHLORIDE 608 560 94 6 10
METOPROLOL TARTRATE 545 449 89 7 13
CITALOPRAM HBR 465 424 74 8 18
AMLODIPINE BESYLATE 461 406 95 9 7
MIRTAZAPINE 399 332 76 10 54
POLYETHYLENE GLYCOL 3350 382 349 89 11 46
GABAPENTIN 363 312 87 12 11
NAMENDA 345 345 30 13 25
TRAMADOL HCL 306 265 57 14 14
SIMVASTATIN 303 291 56 15 6
CLOPIDOGREL 282 265 44 16 19
METFORMIN HCL 275 206 62 17 8
DONEPEZIL HCL 253 236 46 18 31
METOPROLOL SUCCINATE 250 206 52 19 23
ATORVASTATIN CALCIUM 244 211 40 20 9
HYDROCHLOROTHIAZIDE 243 199 52 21 12
MELOXICAM 241 210 43 22 17
PRAVASTATIN SODIUM 230 178 53 23 15
FLUTICASONE PROPIONATE 224 162 56 24 27
SERTRALINE HCL 212 186 31 25 28
CARVEDILOL 209 193 37 26 22
ALPRAZOLAM 197 79 37 B 27 16
PANTOPRAZOLE SODIUM 191 154 35 28 38
TRAZODONE HCL 189 153 32 29 35
LANTUS 183 178* 27 30 61
LORAZEPAM 166 139 36 B 31 40
NOVOLOG 164 159* 25 32 108
PROMETHAZINE HCL 162 109 72 R 33 86
TAMSULOSIN HCL 160 141 28 34 30
ZOLPIDEM TARTRATE 160 117 34 34 20
CYMBALTA 154 108 19 36 36
RANITIDINE HCL 152 132 30 37 34
LYRICA 149 108 20 38 53
FAMOTIDINE* 149 138 25 38 77
FLUOXETINE HCL 149 117 24 38 41
WARFARIN SODIUM 146 119 18 41 21
DIOVAN 142 142 23 42 56
ESCITALOPRAM OXALATE 137 132* 23 43 48
CRESTOR 135 123 16 44 39
PREDNISONE 135 109 71 44 49
PHENYTOIN SODIUM EXTENDED 132 86 14 46 140
CLONAZEPAM 118 50 19 B 47 50
ALLOPURINOL 118 97 25 47 37
PROAIR HFA 115 51 33 49 33
JANTOVEN 113 <11 <11 50 156
QUETIAPINE FUMARATE 109 104* 16 A 51 65
CYCLOBENZAPRINE HCL 105 57 35 R 52 43
ALBUTEROL SULFATE 104 99* 51 53 151
DIAZEPAM 104 28 19 B 53 63
LEVETIRACETAM 103 91 12 55 113
ISOSORBIDE MONONITRATE ER 102 97* 19 56 81
SULFAMETHOXAZOLE-TRIMETHOPRIM 98 86 47 57 79
NEXIUM 98 61 16 57 32
CLONIDINE HCL 96 83 27 59 45
JANUVIA 96 <11 <11 59 73
LISINOPRIL-HYDROCHLOROTHIAZIDE 94 34 25 61 24
ALENDRONATE SODIUM 92 73 21 62 42
VOLTAREN 92 87* 17 62 142
MONTELUKAST SODIUM 88 53 22 64 52
ATENOLOL 88 70 13 64 26
SPIRONOLACTONE 87 71 14 66 83
KLOR-CON M10 86 81* 15 67 133
ADVAIR DISKUS 86 75 23 67 51
DIGOXIN 85 <11 <11 69 114
PAROXETINE HCL 85 63 16 69 59
BACLOFEN 84 52 16 71 109
DIVALPROEX SODIUM 80 <11 <11 72 89
NITROFURANTOIN MONO-MACRO 80 75* 46 72 147
OXYCODONE HCL 79 48 14 S2 74 69
OXYBUTYNIN CHLORIDE ER 75 70* 16 75 119
OXYCODONE HCL-ACETAMINOPHEN 74 38 16 S2 76 72
FINASTERIDE 72 72 13 77 110
KLOR-CON M20 71 66* 14 78 99
LEVOFLOXACIN 71 60 52 78 87
CARBIDOPA-LEVODOPA 70 65* 11 80 125
CLONIDINE 69 <11 <11 81 225
GLYBURIDE 68 <11 <11 R 82 80
TAMIFLU 66 61* 66 83 319
ENALAPRIL MALEATE 65 <11 <11 84 64
ROPINIROLE HCL 64 59* 11 85 70
IBUPROFEN 63 43 19 86 74
AMIODARONE HCL 63 63 14 86 149
AZITHROMYCIN 63 45 56 86 44
LOPERAMIDE 62 57* 46 89 172
AMITRIPTYLINE HCL 61 30 13 R 90 75
NAPROXEN 60 55* 22 91 93
ABILIFY 60 <11 <11 A 91 98
GLIPIZIDE 60 43 11 91 57
CARISOPRODOL 59 21 14 R 94 68
RISPERIDONE 59 <11 <11 A 94 71
VENLAFAXINE HCL ER 57 44 11 96 95
TOPIRAMATE 57 20 16 96 153
OXYCONTIN 57 <11 <11 S2 96 103
ONDANSETRON HCL* 56 37 23 99 197
CELEBREX 56 <11 <11 99 82
HYDROXYZINE HCL 54 33 14 R 101 146
PRIMIDONE 54 <11 <11 101 277
TRIAMCINOLONE ACETONIDE 54 49* 29 101 121
PROPRANOLOL HCL 53 38 13 104 130
DETROL LA 53 <11 <11 104 135
AGGRENOX 53 <11 <11 104 186
SUCRALFATE 51 <11 <11 107 129
OXYCODONE-ACETAMINOPHEN 50 <11 <11 S2 108 143
HUMALOG 50 35 12 108 206
TIZANIDINE HCL 50 28 11 108 84
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 24, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.